Can Amiodarone Affect Your Eyes?

If you take amiodarone for a heart rhythm problem, you may wonder whether the medicine can affect your eyesight. It can cause changes in the eyes, but the most common are tiny corneal deposits, known as cornea verticillata, which are usually harmless. You may have no symptoms at all, although some people notice mild blurred vision or coloured haloes around bright lights.

A much rarer concern is amiodarone-associated optic neuropathy, which affects the optic nerve and can reduce vision, alter colour perception or affect your visual field. If you notice persistent, unexplained or worsening changes in your sight, arrange a prompt eye assessment. Do not stop amiodarone yourself, as it may be treating a serious heart rhythm problem.

What Is Amiodarone?

Amiodarone is an anti-arrhythmic medicine used to treat certain abnormal heart rhythms. You may be prescribed it when an arrhythmia is serious or other treatments have not worked well enough, and you usually need regular medical monitoring because it can affect several organs.

Amiodarone remains in your body for a long time and can affect your thyroid, liver, lungs, nervous system, skin and eyes. You should therefore attend recommended checks, which may include thyroid and liver blood tests, electrolyte monitoring and ECGs.

What Is the Most Common Eye Effect of Amiodarone?

The most common eye effect of amiodarone is tiny corneal deposits called cornea verticillata. You may have no symptoms, but you can sometimes notice blurred vision or coloured haloes around bright lights.

These deposits are usually harmless and rarely affect your sight significantly. You should not stop amiodarone just because you have them, but if you notice persistent changes, you should have your eyes assessed by an eye specialist.

Why Does Amiodarone Produce Corneal Deposits?

Amiodarone and its metabolites can accumulate in corneal cells and form tiny deposits. You may notice no symptoms because these deposits usually form fine, whorl-like patterns without significantly affecting how light passes through your cornea.

Your cornea needs to stay clear for good vision, so visible deposits may look concerning during an eye examination. However, these deposits are usually benign and generally do not require amiodarone to be stopped on their own.

Can Corneal Deposits Blur Your Vision?

Corneal deposits can sometimes cause blurred vision or coloured haloes around bright lights, particularly at night. You may notice haloes around headlights or lamps, but many people have no symptoms and you can usually maintain normal vision despite the deposits.

If your vision becomes significantly blurred, you should not assume the deposits are responsible. You should have an eye examination to check for other causes, such as cataracts, glaucoma, retinal disease, prescription changes or optic nerve problems.

Are Coloured Haloes Around Lights Dangerous?

Coloured haloes can occur with amiodarone-related corneal deposits and are usually harmless. You may notice them around headlights or streetlights at night, particularly in dazzling light, because the tiny deposits can scatter light.

However, haloes can also occur with cataracts, corneal swelling or acute angle-closure glaucoma. You should seek urgent medical attention if you develop haloes with severe eye pain, redness, headache, nausea or sudden vision changes, rather than assuming you can blame the medicine.

Do Amiodarone Corneal Deposits Go Away?

Yes, amiodarone corneal deposits usually regress after treatment is stopped and may take several months to disappear. You may still notice them for some time because amiodarone remains in your body tissues long after the medicine is discontinued.

You should not stop amiodarone simply to clear the deposits, as it may be controlling a serious heart rhythm problem. Your doctor can decide whether treatment should continue, change or stop based on your heart condition and overall health.

Can Amiodarone Affect the Optic Nerve?

Rarely, amiodarone has been associated with optic neuropathy affecting the nerve that carries visual signals from your retina to your brain. You may develop reduced vision, changes in colour perception or visual field problems, and severe cases can threaten sight.

This is very different from harmless corneal deposits. You should seek prompt eye assessment if you develop unexplained or worsening vision changes while taking amiodarone, as optic nerve problems need prompt investigation so the cause and appropriate management can be determined.

How Amiodarone-Related Corneal Deposits and Optic Neuropathy Differ

Feature	Corneal microdeposits	Amiodarone-associated optic neuropathy
How common?	Very common	Very rare in current UK product information
Area affected	Cornea at the front of the eye	Optic nerve
Typical symptoms	Often none; sometimes haloes or mild blur	Reduced or dim vision, colour changes or visual-field loss
Effect on sight	Usually little or no significant loss of visual acuity	Can cause significant and potentially permanent visual loss
Typical course	Usually benign and may regress after treatment ends	Requires prompt specialist assessment
Does amiodarone usually need to stop?	No, deposits alone generally do not require discontinuation	UK product information advises withdrawal if optic neuropathy or optic neuritis is identified, with treatment changes coordinated by the prescribing clinical team.

Is It Proven That Amiodarone Causes Optic Neuropathy?

The link between amiodarone and optic neuropathy is recognised, but proving direct causation can be difficult. You may have other risk factors, such as high blood pressure, diabetes or sleep apnoea, which are also associated with an increased risk of non-arteritic anterior ischaemic optic neuropathy (NAION).

If you take amiodarone and develop new vision changes, you should have prompt eye assessment. Doctors need to consider your medical history, symptoms and examination findings, as you may have optic nerve disease that is unrelated to the medicine.

Research Insight

Amiodarone-associated optic neuropathy can be difficult to distinguish from non-arteritic anterior ischaemic optic neuropathy because people taking amiodarone often already have cardiovascular risk factors that can increase their risk of optic nerve disease.

In one nationwide study involving 6,175 people treated with amiodarone and 24,700 controls, optic neuropathy was recorded in 0.3% of amiodarone users compared with 0.1% of controls. After adjustment, amiodarone use was associated with about twice the risk of optic neuropathy. However, observational studies cannot prove that the medicine directly caused every case.

What Symptoms Can Amiodarone-Associated Optic Neuropathy Cause?

Amiodarone-associated optic neuropathy may cause reduced vision, faded colours or changes in your visual field. You may notice that vision becomes dimmer or colours appear less vivid in one eye, although some people have few or no symptoms initially.

If you take amiodarone and notice sudden or worsening vision changes, you should seek prompt medical assessment. Amiodarone-associated optic neuropathy is often painless. Any new reduction in vision, colour perception or visual field should be assessed promptly, while eye pain with visual change should also be investigated because it may suggest another eye or optic nerve condition.

How Does Amiodarone-Associated Optic Neuropathy Differ From NAION?

NAION usually causes sudden, painless vision loss in one eye, with optic disc swelling that settles within weeks. Amiodarone-associated optic neuropathy is more often gradual, may affect both eyes and can cause optic disc swelling that lasts longer.

However, the patterns can overlap, so you should not assume the cause yourself. Your ophthalmologist will consider your symptoms, timing, colour vision, visual fields, cardiovascular risk factors and optic disc appearance before deciding whether amiodarone may be involved.

How Soon Can Optic Nerve Problems Appear?

There is no fixed timeframe for amiodarone-associated optic neuropathy. Reported cases have developed at different points during treatment. In one published case series, 88% of cases developed within the first 12 months of treatment, with a median onset of four months. However, later presentations have also been reported, so these figures should not be treated as a fixed individual timeline.

• Early onset: Some cases have appeared within the first few months.
• Later onset: Optic nerve problems can also develop after years of treatment.
• Unpredictable timing: Treatment duration alone cannot predict who will be affected.
• New symptoms matter: Any unexplained change in vision should be assessed promptly.

Corneal deposits are much more common than optic neuropathy, so these two eye effects should not be confused.

How Would an Eye Specialist Check for Optic Neuropathy?

Your eye specialist will check how clearly you see, your colour vision and your pupils, then examine your optic nerves after dilating your eyes. You may also have an OCT scan to assess the retinal nerve fibre layer and identify swelling or later thinning.

A visual-field test can detect areas of reduced vision that you may not notice yourself. You should know that additional blood tests or scans may sometimes be needed, as your doctor must identify the cause of any optic nerve abnormality before deciding on treatment.

Do You Need Regular Eye Tests While Taking Amiodarone?

Regular eye care is important while you take amiodarone. Even if your vision seems unchanged, keep up with the eye checks recommended for you and make sure your optometrist or ophthalmologist knows that you take this medicine.

Do not wait until your next routine appointment if your vision becomes blurred, dimmer or noticeably different. New visual symptoms should be assessed promptly so your eye specialist can check whether they are related to amiodarone or another eye condition.

UK Guidance Note

Current UK product information recommends annual ophthalmological examination for people taking oral amiodarone when blurred or reduced vision is not present. NHS Specialist Pharmacy Service guidance also advises encouraging patients to visit an optician annually.

If blurred or reduced vision develops, a prompt complete ophthalmological examination, including fundoscopy, is recommended. If optic neuropathy or optic neuritis is identified, current UK prescribing information advises withdrawal of amiodarone because of the potential risk of progression to blindness. Treatment changes should be coordinated with the clinician managing your heart rhythm rather than made independently.

Should Amiodarone Be Stopped Because of Corneal Deposits?

Usually not. Corneal deposits are very common with amiodarone and are generally harmless. You should not stop the medicine simply because deposits are found, as doing so could increase your risk of a serious heart rhythm problem.

If you notice mild haloes or blurred vision, your cardiology and eye teams can check whether the corneal deposits are responsible. You should have further assessment if vision changes are significant or if optic nerve problems are suspected, as this requires a different approach.

What Happens If Optic Neuropathy Is Suspected?

If you develop blurred or reduced vision while taking amiodarone, you should have prompt ophthalmic assessment. Your eye specialist may examine your optic nerves and, if optic neuropathy is identified, discuss stopping amiodarone with your cardiologist because the condition can threaten sight.

You should not stop the medicine yourself, as it may be controlling a serious heart rhythm problem. Even after stopping, amiodarone can remain in your tissues for months, so you may not see immediate improvement and any existing optic nerve damage may not be fully reversible.

When Should You Seek an Eye Assessment?

You should arrange an eye examination if you develop persistent blurred vision, troublesome coloured haloes or changes in colour perception while taking amiodarone. You should seek urgent assessment if your vision suddenly becomes dimmer, colours look washed out in one eye or part of your visual field disappears.

You should tell your eye specialist that you take amiodarone, including your dose and treatment duration. You should not stop or change the medicine yourself; instead, contact the doctor managing your heart condition so any treatment changes can be made safely.

Myth vs Fact

Myth	Fact
Corneal deposits mean amiodarone is damaging your eyesight.	Usually not. Corneal microdeposits are very common and generally benign, with little effect on visual acuity.
Amiodarone should always be stopped when corneal deposits are found.	No. Deposits alone generally do not require amiodarone to be stopped.
Coloured haloes always mean a serious eye problem.	No. Amiodarone-related corneal deposits can cause harmless haloes, but haloes with severe pain, redness, nausea or sudden visual loss need urgent assessment.
Every optic nerve problem in someone taking amiodarone is caused by the medicine.	No. NAION and other optic neuropathies can occur in the same population, so specialist investigation is needed.
Amiodarone-associated optic neuropathy always starts suddenly in one eye.	No. It is often described as more gradual, bilateral and associated with prolonged disc swelling, although presentations can overlap with NAION.
You should stop amiodarone yourself if your sight changes.	No. Seek prompt eye assessment and contact the clinician managing your heart condition. Medication changes need medical supervision.

Key Takeaways

• Amiodarone commonly causes tiny corneal deposits called cornea verticillata, which are usually benign.
• Corneal deposits may cause coloured haloes or mild blurred vision but generally do not significantly reduce visual acuity.
• Corneal deposits alone are not usually a reason to stop amiodarone.
• Amiodarone-associated optic neuropathy is much less common but can cause significant or permanent visual loss.
• Optic neuropathy may cause dimmer vision, reduced colour perception or visual-field changes and can sometimes affect both eyes.
• Current UK oral amiodarone information recommends annual eye examination and prompt ophthalmological assessment if blurred or reduced vision develops.
• Amiodarone-associated optic neuropathy can resemble NAION, so an ophthalmologist needs to investigate the cause rather than assuming the medicine is responsible.
• Do not stop or change amiodarone yourself because it may be treating a serious heart rhythm problem; any change should be coordinated with your medical team.

Frequently Asked Questions

1. Can amiodarone affect your eyes and vision?
   Yes, amiodarone can affect your eyes, particularly with long-term use. The most common effect is harmless corneal deposits, although blurred vision, coloured haloes and, rarely, optic nerve problems can occur.
2. What is the most common eye effect of amiodarone?
   The most common eye effect is cornea verticillata, where tiny deposits form in the cornea. You may have no symptoms, although some people notice blurred vision or coloured haloes around bright lights.
3. Can amiodarone cause blurred vision?
   Amiodarone-related corneal deposits can sometimes cause blurred vision or haloes, particularly around lights at night. If your vision becomes persistently or significantly blurred, you should have an eye examination to check for other possible causes.
4. Are coloured haloes around lights caused by amiodarone dangerous?
   Coloured haloes can occur because amiodarone causes deposits in the cornea, and they are usually harmless. However, haloes accompanied by severe eye pain, redness, headache, nausea or sudden vision changes need urgent assessment because they can have other causes.
5. Do amiodarone corneal deposits go away?
   The deposits usually regress after amiodarone is stopped and may take several months to disappear. You should not stop amiodarone yourself, as it may be controlling a serious heart rhythm problem.
6. Can amiodarone damage the optic nerve?
   Rarely, amiodarone can be associated with optic neuropathy, which affects the optic nerve and may reduce vision or colour perception. New or worsening visual changes while taking amiodarone should be assessed promptly.
7. What symptoms can amiodarone-associated optic neuropathy cause?
   You may notice reduced or dimmer vision, faded colours or changes in your visual field. These symptoms can overlap with other optic nerve conditions, so an ophthalmologist needs to investigate the cause.
8. Do you need regular eye tests while taking amiodarone?
   Regular eye care is important during amiodarone treatment. Current UK product information recommends annual ophthalmological examination, and new blurred or reduced vision should be assessed promptly. You should also tell your optometrist or ophthalmologist that you take amiodarone so they can interpret any findings appropriately.
9. Should you stop amiodarone if corneal deposits are found?
   Usually, no. Corneal deposits are common and generally harmless, so you should not stop the medicine simply because they have been detected.
10. When should you seek an eye assessment while taking amiodarone?
    You should arrange an eye examination if you develop persistent blurred vision, troublesome haloes or changes in colour perception. Sudden dimming of vision, loss of part of your visual field or significant new visual changes needs prompt or urgent assessment.

Final Thoughts: Protecting Your Eyes While Taking Amiodarone

Amiodarone can cause common and usually harmless corneal deposits, but rare optic nerve problems can affect your vision and need prompt assessment. If you notice persistent blurred vision, troublesome haloes, changes in colour perception or sudden dimming of your sight, you should arrange an eye examination rather than assuming the symptoms are simply a side effect.

If you have any concerns about your eyesight, you can contact our team at Eye Clinic London for a comprehensive assessment and advice on the next steps that may be appropriate for you.

References:

1. Green, M.B. and Duker, J.S. (2023) ‘Adverse ocular effects of systemic medications’, Life, 13(3), 660. Available at: https://www.mdpi.com/2075-1729/13/3/660
2. Sahyoun, J.-Y., Sabeti, S. and Robert, M.-C. (2022) ‘Drug-induced corneal deposits: an up-to-date review’, BMJ Open Ophthalmology, 7(1), e000943. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8961126/
3. Wang, A.-G. and Cheng, H.-C. (2017) ‘Amiodarone-associated optic neuropathy: clinical review’, Neuro-Ophthalmology, 41(2), pp. 55–58. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5354097/
4. Cheng, H.-C. et al. (2015) ‘Amiodarone-associated optic neuropathy: a nationwide study’, Ophthalmology, 122(12), pp. 2553–2559. Available at: https://pubmed.ncbi.nlm.nih.gov/26391464/
5. Dammacco, R. et al. (2025) ‘Amiodarone-induced ocular and extra-ocular toxicity: a retrospective cohort study’, Clinical and Experimental Medicine, 25, 68. Available at: https://pubmed.ncbi.nlm.nih.gov/40025381/